Coherus BioSciences has completed the sale of its Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals under an ...

GreensKeeper Asset Management, an investment management company, released its first quarter 2025 investor letter. A copy of ...

– Coherus to focus exclusively on its innovative novel oncology programs including: – LOQTORZI®, a revenue-generating and differentiated PD-1 inhibitor; – Casdozokitug, a first-in-class interleukin-27 ...

That’s one way that Chiesi Group – an Italian family business-turned-global pharma ... franchise, told pharmaphorum. “It's really embedded into the core decision-making of the company ...

Lathrop GPM LLP is proud to announce that Malaika Tyson has joined the firm as a partner in the Intellectual Property practice group. She will be based in the Chicago office, where her practice will ...

As the biotech industry continues to rapidly evolve, staying ahead of the curve requires agile decision-making and robust commercialization strategies. The expert speakers will offer practical ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

GNC, a global leader in nutritional supplements, has launched a unique summer internship program – All Play No Work – a bold new initiative that merges fitness, learning, and personal transformation.

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

The offer includes $205 million in cash at closing and up to $50 million in contingent value right payments tied to the ...